Home » Topics » Disease categories and therapies » Infection

Infection
RSS

BioCryst updates influenza neuraminidase inhibitor program with R.W. Johnson

Jan. 10, 2000

Health Canada approves first pill to treat influenza

Jan. 10, 2000

Abbott's new ketolide ABT-773 will be codeveloped by Taisho

Jan. 10, 2000

NC-1175 possesses ATPase-targeted antifungal activity

Jan. 10, 2000

Merck describes novel penems with activity against resistant staphylococci

Jan. 10, 2000

CRL-1072 enhances antibiotic activity against MAI

Jan. 10, 2000

Japanese investigators prepare new agents for influenza

Jan. 5, 2000

Total synthesis, structure reported for antifungal antibiotics produced by Penicillium

Jan. 4, 2000

Miltefosine tested as oral treatment for leishmaniasis

Jan. 4, 2000

ViroPharma licenses Battelle's drug delivery technology for its anti-RSV products

Jan. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...